MMM
GILD icon

Mendel Money Management’s Gilead Sciences GILD Stock Holding History

Mendel Money Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Sell
6,125
-2,662
-30% -$351K 0.28% 84
2026
Q1 		$1.22M Sell
8,787
-390
-4% -$54.6K 0.51% 63
2025
Q4 		$1.13M Sell
9,177
-910
-9% -$111K 0.47% 61
2025
Q3 		$1.12M Sell
10,087
-100
-1% -$11.4K 0.47% 59
2025
Q2 		$1.13M Sell
10,187
-43
-0.4% -$4.58K 0.5% 60
2025
Q1 		$1.15M Buy
10,230
+10
+0.1% +$1.03K 0.54% 53
2024
Q4 		$944K Sell
10,220
-25
-0.2% -$2.25K 0.42% 63
2024
Q3 		$859K Buy
10,245
+50
+0.5% +$3.81K 0.37% 70
2024
Q2 		$699K Buy
10,195
+225
+2% +$15K 0.33% 73
2024
Q1 		$730K Buy
9,970
+180
+2% +$13.8K 0.34% 71
2023
Q4 		$793K Buy
9,790
+524
+6% +$40.8K 0.38% 61
2023
Q3 		$694K Buy
9,266
+706
+8% +$54.3K 0.37% 59
2023
Q2 		$660K Buy
8,560
+75
+0.9% +$5.98K 0.34% 62
2023
Q1 		$704K Buy
8,485
+115
+1% +$9.53K 0.38% 58
2022
Q4 		$719K Sell
8,370
-30
-0.4% -$2.38K 0.41% 55
2022
Q3 		$518K Buy
8,400
+3,230
+62% +$204K 0.32% 62
2022
Q2 		$320K Sell
5,170
-3,145
-38% -$195K 0.19% 87
2022
Q1 		$494K Buy
+8,315
New +$532K 0.24% 79
2015
Q2 		$1.82M Sell
15,580
-50
-0.3% -$5.46K 1.7% 26
2015
Q1 		$1.53M Buy
15,630
+560
+4% +$56.9K 1.43% 27
2014
Q4 		$1.42M Buy
15,070
+6,410
+74% +$663K 1.34% 30
2014
Q3 		$922K Buy
+8,660
New +$848K 0.9% 32

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mendel Money Management's GILD Position: Q2 2026 in Review

Mendel Money Management reduced its Gilead Sciences (GILD) stake by 30% in Q2 2026, selling an estimated $351K and leaving 6,125 shares worth $774K. The position accounts for 0.28% of the portfolio, ranked #84.

Mendel Money Management first reported a position in GILD in Q3 2014 and has held it in 22 quarters since. The position peaked at $1.82M in Q2 2015. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Mendel Money Management held 6,125 shares of Gilead Sciences worth $774K as of Q2 2026.
  • Mendel Money Management sold 2,662 Gilead Sciences shares in Q2 2026, an estimated $351K.
  • Gilead Sciences made up 0.28% of Mendel Money Management's portfolio in Q2 2026, its #84 holding.
  • Mendel Money Management first reported a position in Gilead Sciences in Q3 2014 and has held it in 22 quarters since.
  • Mendel Money Management's Gilead Sciences position peaked at $1.82M in Q2 2015.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mendel Money Management's 13F filing for Q2 2026, filed 30 Jul 2026.